138 related articles for article (PubMed ID: 19132983)
21. The CD4(+) regulatory T-cells is decreased in adults with latent autoimmune diabetes.
Yang Z; Zhou Z; Huang G; Ling H; Yan X; Peng J; Li X
Diabetes Res Clin Pract; 2007 Apr; 76(1):126-31. PubMed ID: 17005288
[TBL] [Abstract][Full Text] [Related]
22. FOXP3-expressing CD4(+) T-cell numbers increase in areas of duodenal gastric metaplasia and are associated to CD4(+) T-cell aggregates in the duodenum of Helicobacter pylori-infected duodenal ulcer patients.
Kindlund B; Sjöling A; Hansson M; Edebo A; Hansson LE; Sjövall H; Svennerholm AM; Lundin BS
Helicobacter; 2009 Jun; 14(3):192-201. PubMed ID: 19702849
[TBL] [Abstract][Full Text] [Related]
23. [Analysis of CD4+CD25+Foxp3+ regulatory T cells in patients of haemorrhagic fever with renal syndrome].
Nie ST; Li Q; Wang HY
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):817-9. PubMed ID: 19595120
[TBL] [Abstract][Full Text] [Related]
24. Role of regulatory T cells for the treatment of type 1 diabetes mellitus.
Jaeckel E; Mpofu N; Saal N; Manns MP
Horm Metab Res; 2008 Feb; 40(2):126-36. PubMed ID: 18283631
[TBL] [Abstract][Full Text] [Related]
25. Regulatory T-cells in periapical lesions.
Colić M; Gazivoda D; Vucević D; Majstorović I; Vasilijić S; Rudolf R; Brkić Z; Milosavljević P
J Dent Res; 2009 Nov; 88(11):997-1002. PubMed ID: 19828886
[TBL] [Abstract][Full Text] [Related]
26. Deficiency of regulatory T cells in children with autoimmune neutropenia.
Nakamura K; Miki M; Mizoguchi Y; Karakawa S; Sato T; Kobayashi M
Br J Haematol; 2009 Jun; 145(5):642-7. PubMed ID: 19344427
[TBL] [Abstract][Full Text] [Related]
27. Regulatory T-cells are possible effect prediction markers of immunotherapy for cancer patients.
Wada J; Yamasaki A; Nagai S; Yanai K; Fuchino K; Kameda C; Tanaka H; Koga K; Nakashima H; Nakamura M; Tanaka M; Katano M; Morisaki T
Anticancer Res; 2008; 28(4C):2401-8. PubMed ID: 18751426
[TBL] [Abstract][Full Text] [Related]
28. Forkhead box P3 (FOXP3) mRNA expression immediately after living-donor liver transplant.
Sakamoto R; Asonuma K; Zeledon Ramirez ME; Yoshimoto K; Nishimori A; Inomata Y
Exp Clin Transplant; 2009 Mar; 7(1):8-12. PubMed ID: 19364305
[TBL] [Abstract][Full Text] [Related]
29. Reduced frequency of CD4(+)CD25(HIGH)FOXP3(+) cells and diminished FOXP3 expression in patients with Common Variable Immunodeficiency: a link to autoimmunity?
Genre J; Errante PR; Kokron CM; Toledo-Barros M; Câmara NO; Rizzo LV
Clin Immunol; 2009 Aug; 132(2):215-21. PubMed ID: 19394278
[TBL] [Abstract][Full Text] [Related]
30. Cryopreserved peripheral blood mononuclear cells are suitable for the assessment of immunological markers in type 1 diabetic children.
Axelsson S; Faresjö M; Hedman M; Ludvigsson J; Casas R
Cryobiology; 2008 Dec; 57(3):201-8. PubMed ID: 18761006
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis.
Sfikakis PP; Souliotis VL; Fragiadaki KG; Moutsopoulos HM; Boletis JN; Theofilopoulos AN
Clin Immunol; 2007 Apr; 123(1):66-73. PubMed ID: 17275413
[TBL] [Abstract][Full Text] [Related]
32. GAD-alum treatment induces GAD65-specific CD4+CD25highFOXP3+ cells in type 1 diabetic patients.
Hjorth M; Axelsson S; Rydén A; Faresjö M; Ludvigsson J; Casas R
Clin Immunol; 2011 Jan; 138(1):117-26. PubMed ID: 21044870
[TBL] [Abstract][Full Text] [Related]
33. Regulatory T cells in atopic dermatitis: epidermal dendritic cell clusters may contribute to their local expansion.
Szegedi A; Baráth S; Nagy G; Szodoray P; Gál M; Sipka S; Bagdi E; Banham AH; Krenács L
Br J Dermatol; 2009 May; 160(5):984-93. PubMed ID: 19222459
[TBL] [Abstract][Full Text] [Related]
34. GAD65- and proinsulin-specific CD4+ T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects.
Oling V; Marttila J; Ilonen J; Kwok WW; Nepom G; Knip M; Simell O; Reijonen H
J Autoimmun; 2005 Nov; 25(3):235-43. PubMed ID: 16263242
[TBL] [Abstract][Full Text] [Related]
35. Regulatory T cells in paraneoplastic neurological syndromes.
Tani T; Tanaka K; Idezuka J; Nishizawa M
J Neuroimmunol; 2008 May; 196(1-2):166-9. PubMed ID: 18455243
[TBL] [Abstract][Full Text] [Related]
36. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
Westerlund A; Ankelo M; Ilonen J; Knip M; Simell O; Hinkkanen AE
J Autoimmun; 2005 Mar; 24(2):153-67. PubMed ID: 15829408
[TBL] [Abstract][Full Text] [Related]
37. Autoreactive T cell response in CD25-negative fraction of peripheral blood mononuclear cells in established type 1 diabetes.
Moriyama H; Kotani R; Katsuta A; Kameno M; Arai T; Okumachi Y; Kishi M; Yamada K; Yasuda H; Hara K; Yokono K; Nagata M
Ann N Y Acad Sci; 2008 Dec; 1150():278-81. PubMed ID: 19120313
[TBL] [Abstract][Full Text] [Related]
38. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
39. Immunoregulatory T cells in the peripheral blood of melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cell vaccination.
Nakai N; Katoh N; Kitagawa T; Ueda E; Takenaka H; Kishimoto S
J Dermatol Sci; 2009 Apr; 54(1):31-7. PubMed ID: 19157789
[TBL] [Abstract][Full Text] [Related]
40. Clinical significance of regulatory T cells in patients with myelodysplastic syndrome.
Hamdi W; Ogawara H; Handa H; Tsukamoto N; Nojima Y; Murakami H
Eur J Haematol; 2009 Mar; 82(3):201-7. PubMed ID: 19018862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]